These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2903127)
1. Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product. Tweten RK Infect Immun; 1988 Dec; 56(12):3228-34. PubMed ID: 2903127 [TBL] [Abstract][Full Text] [Related]
2. Nucleotide sequence of the gene for perfringolysin O (theta-toxin) from Clostridium perfringens: significant homology with the genes for streptolysin O and pneumolysin. Tweten RK Infect Immun; 1988 Dec; 56(12):3235-40. PubMed ID: 2903128 [TBL] [Abstract][Full Text] [Related]
3. An upstream regulatory sequence stimulates expression of the perfringolysin O gene of Clostridium perfringens. Shimizu T; Okabe A; Minami J; Hayashi H Infect Immun; 1991 Jan; 59(1):137-42. PubMed ID: 1987025 [TBL] [Abstract][Full Text] [Related]
4. The virR gene, a member of a class of two-component response regulators, regulates the production of perfringolysin O, collagenase, and hemagglutinin in Clostridium perfringens. Shimizu T; Ba-Thein W; Tamaki M; Hayashi H J Bacteriol; 1994 Mar; 176(6):1616-23. PubMed ID: 8132455 [TBL] [Abstract][Full Text] [Related]
5. Kinetic aspects of the aggregation of Clostridium perfringens theta-toxin on erythrocyte membranes. A fluorescence energy transfer study. Harris RW; Sims PJ; Tweten RK J Biol Chem; 1991 Apr; 266(11):6936-41. PubMed ID: 2016307 [TBL] [Abstract][Full Text] [Related]
6. Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model. Singh A; Rawat P; Choudhury D; Dixit A Immunol Res; 2022 Apr; 70(2):240-255. PubMed ID: 35032316 [TBL] [Abstract][Full Text] [Related]
7. Perfringolysin O expression in Clostridium perfringens is independent of the upstream pfoR gene. Awad MM; Rood JI J Bacteriol; 2002 Apr; 184(7):2034-8. PubMed ID: 11889112 [TBL] [Abstract][Full Text] [Related]
9. Non-toxic perfringolysin O and α-toxin derivatives as potential vaccine candidates against bovine necrohaemorrhagic enteritis. Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Van Immerseel F Vet J; 2016 Nov; 217():89-94. PubMed ID: 27810219 [TBL] [Abstract][Full Text] [Related]
10. Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli: sequence and homology with a Bacillus cereus phospholipase C. Leslie D; Fairweather N; Pickard D; Dougan G; Kehoe M Mol Microbiol; 1989 Mar; 3(3):383-92. PubMed ID: 2546005 [TBL] [Abstract][Full Text] [Related]
11. R468A mutation in perfringolysin O destabilizes toxin structure and induces membrane fusion. Kulma M; Kacprzyk-Stokowiec A; Kwiatkowska K; Traczyk G; Sobota A; Dadlez M Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1075-1088. PubMed ID: 28263714 [TBL] [Abstract][Full Text] [Related]
12. Crucial role of perfringolysin O D1 domain in orchestrating structural transitions leading to membrane-perforating pores: a hydrogen-deuterium exchange study. Kacprzyk-Stokowiec A; Kulma M; Traczyk G; Kwiatkowska K; Sobota A; Dadlez M J Biol Chem; 2014 Oct; 289(41):28738-52. PubMed ID: 25164812 [TBL] [Abstract][Full Text] [Related]
13. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Shepard LA; Heuck AP; Hamman BD; Rossjohn J; Parker MW; Ryan KR; Johnson AE; Tweten RK Biochemistry; 1998 Oct; 37(41):14563-74. PubMed ID: 9772185 [TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of flanking regions of the pfoA gene of Clostridium perfringens: beta-galactosidase gene (pbg) is located in the 3'-flanking region. Shimizu T; Kobayashi T; Ba-Thein W; Ohtani K; Hayashi H Microbiol Immunol; 1995; 39(9):677-86. PubMed ID: 8577281 [TBL] [Abstract][Full Text] [Related]
15. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. O'Brien DK; Melville SB Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015 [TBL] [Abstract][Full Text] [Related]
16. Isolation of a tryptic fragment from Clostridium perfringens theta-toxin that contains sites for membrane binding and self-aggregation. Tweten RK; Harris RW; Sims PJ J Biol Chem; 1991 Jul; 266(19):12449-54. PubMed ID: 2061320 [TBL] [Abstract][Full Text] [Related]
17. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens. Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514 [TBL] [Abstract][Full Text] [Related]
18. The spatial organization of the VirR boxes is critical for VirR-mediated expression of the perfringolysin O gene, pfoA, from Clostridium perfringens. Cheung JK; Dupuy B; Deveson DS; Rood JI J Bacteriol; 2004 Jun; 186(11):3321-30. PubMed ID: 15150217 [TBL] [Abstract][Full Text] [Related]
19. Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin O), a cholesterol-binding cytolysin. Sekino-Suzuki N; Nakamura M; Mitsui KI; Ohno-Iwashita Y Eur J Biochem; 1996 Nov; 241(3):941-7. PubMed ID: 8944786 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli. Perelle S; Gibert M; Boquet P; Popoff MR Infect Immun; 1993 Dec; 61(12):5147-56. PubMed ID: 8225592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]